Cargando…
Single patient classifier as a prognostic biomarker in pT1N1 gastric cancer: Results from two large Korean cohorts
OBJECTIVE: Benefits of adjuvant treatment in pT1N1 gastric cancer (GC) remain controversial. Additionally, an effective biomarker for early GC is the need of the hour. The prognostic and predictive roles of single patient classifier (SPC) were validated in stage II/III GC. In this study, we aimed to...
Autores principales: | Choi, Yoon Young, Jang, Eunji, Kim, Hyunki, Kim, Kyoung-Mee, Noh, Sung Hoon, Sohn, Tae Sung, Huh, Yong-Min, An, Ji Yeong, Cheong, Jae-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580794/ https://www.ncbi.nlm.nih.gov/pubmed/34815632 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.05.05 |
Ejemplares similares
-
Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
por: Shin, Hyun Beak, et al.
Publicado: (2017) -
Modification of the TNM Staging System for Stage II/III Gastric Cancer Based on a Prognostic Single Patient Classifier Algorithm
por: Choi, Yoon Young, et al.
Publicado: (2018) -
Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer
por: Kim, Jun Yong, et al.
Publicado: (2023) -
Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer
por: Bae, Yoon Sung, et al.
Publicado: (2015) -
Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
por: Roh, Chul Kyu, et al.
Publicado: (2019)